A detailed history of Kula Investments, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Kula Investments, LLC holds 14,547 shares of BMY stock, worth $708,438. This represents 0.25% of its overall portfolio holdings.

Number of Shares
14,547
Previous 24,702 41.11%
Holding current value
$708,438
Previous $1.78 Billion 43.27%
% of portfolio
0.25%
Previous 0.52%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$65.71 - $74.53 $667,285 - $756,852
-10,155 Reduced 41.11%
14,547 $1.01 Billion
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $1.69 Million - $2 Million
24,702 New
24,702 $1.78 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $104B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Kula Investments, LLC Portfolio

Follow Kula Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kula Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kula Investments, LLC with notifications on news.